Theacrine

Theacrine is a purine alkaloid belonging to the same broad chemical family as caffeine and theobromine. Its systematic name is 1,3,7,9-tetramethyluric acid, and it has the molecular formula C9H12N4O3; structurally it can be viewed as a methylated derivative of uric acid that closely resembles caffeine. It occurs naturally in a bitter Chinese tea known as kucha, made from Camellia assamica var. kucha, and in the pulp of the Amazonian cupuacu fruit and certain coffee species. In the kucha plant, theacrine is thought to be produced from caffeine through a short biosynthetic pathway ^[2].

Research on theacrine has examined a range of activities, from central-nervous-system stimulation to effects on metabolism and inflammation. In rodents, theacrine increased spontaneous movement and activity in a way that did not fade with repeated dosing, and it was reported to have anti-inflammatory and pain-relieving properties ^[1]. In a high-fat-diet model, it lessened fatty liver and improved energy expenditure by activating the mitochondrial enzyme SIRT3 and enhancing fatty-acid oxidation ^[3], and in laboratory studies of breast cancer cells it interfered with a cellular program tied to metastasis ^[4]. Much of this evidence comes from cell and animal experiments, with a smaller body of human data focused on the supplement setting.

As a supplement, theacrine is marketed for feelings of energy, focus, and motivation, frequently in pre-workout and nootropic products and sometimes combined with caffeine. A controlled study in healthy adults taking a nature-identical form of theacrine daily for eight weeks found that clinical safety markers, including heart rate, blood pressure, and blood tests of liver, kidney, and immune function, stayed within normal limits, and that its perceived energizing effects did not diminish over time, suggesting little of the habituation seen with caffeine ^[2]. It also has a notably long half-life, on the order of a day, which is longer than that of caffeine.

Theacrine is regulated as a dietary supplement ingredient rather than as an approved medicine, so it is not intended to diagnose, treat, or prevent disease. It is not a controlled substance. Although the available safety data over several weeks are reassuring, long-term human studies remain limited, and, as with other stimulants, its combination with caffeine or other active ingredients in commercial products means effects can vary. People who are sensitive to stimulants or who take related medications are generally advised to use caution.

Well tolerated in short human trials at typical doses, with no major changes in heart rate or blood pressure reported in several studies. Because it's a stimulant, sensitive people can still get restlessness or trouble sleeping if taken late. Long-term and high-dose safety data are limited, so megadosing it is unwise. As with any stimulant, people with cardiovascular conditions or on other stimulants should be careful.

Theacrine (1,3,7,9-tetramethyluric acid) is a naturally occurring purine alkaloid first detected as a minor component of Camellia sinensis by Johnson in 1937, and later found in comparatively high abundance in the leaves of kucha (Camellia assamica var. kucha), a bitter wild tea from Yunnan province in China. Biosynthetic work established that theacrine is derived from caffeine through a methyluric-acid intermediate, marking it as a downstream oxidation product of the caffeine pathway.

Kucha itself has a long history of local use as a bitter tonic tea, and the alkaloid drew broader scientific interest for stimulant-like and hepatoprotective effects in rodent studies. In the 2010s the ingredient was commercialized in synthetic form under the trademark TeaCrine by Compound Solutions, positioned as a longer-lasting, lower-crash energy and focus ingredient for supplements. It is sold as a dietary ingredient rather than an approved drug.